Mephenytoin
Back to searchMolecule Structure
Scientific Name
Mephenytoin
Description of the Drug
Mephenytoin is a phenylhydantoin used to treat refractory partial epilepsy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00532
http://www.drugbank.ca/drugs/DB00532
Brand Name(s)
Mesantoin
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL21766 | |
PharmGKB | PA450373 | |
Human Metabolome Database | HMDB0014673 | |
DrugBank | DB00532 | |
PubChem: Thomson Pharma | 14773490 | |
PubChem | 4060 | |
Mcule | MCULE-6021512202 | |
LINCS | LSM-1852 | |
Nikkaji | J4.097E | J66.257G |
BindingDB | 50103593 | |
EPA CompTox Dashboard | DTXSID9023257 | |
DrugCentral | 1695 | |
Brenda | 109149 | |
ChemicalBook | CB0225135 | |
Guide to Pharmacology | 7223 | |
rxnorm | MEPHENYTOIN | |
ChEBI | 6757 |